Lexicon Pharmaceuticals Announces Resignation of President and Chief Operating Officer

THE WOODLANDS, Texas, September 16, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. Lexicon, Inc. (Nasdaq: LXRX) today announced that Jeff Wade, president and chief operating officer, has decided to step down to pursue new opportunities outside Lexicon, effective September 30, 2024. The search for a new chief financial officer is underway.

Over the past 25 years, Mr. Wade has held a series of leadership positions in the financial, corporate development, administrative and legal sectors at Lexicon, most recently serving as president and chief operating officer.